Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A

Pediatric Blood and Cancer

Volumn 56, Issue 2, 2011, Pages 307-310

  Kumar, Riten ^a   Khan, Shakila P ^a   Joshi, Divya Devi ^b   Shaw, Gene R ^c   Ketterling, Rhett P ^a   Feldman, Andrew L ^a  

^a MAYO CLINIC   (United States)

^b Torrance Hospital IPA   (United States)

^c MARSHFIELD CLINIC   (United States)

Author keywords

B cell acute lymphoblastic leukemia; CDKN2A; Histiocytic sarcoma; P16INK4A; Trans differentiation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; CDKN2A GENE; CHILD; CHILDHOOD CANCER; CYTOGENETICS; GENE DELETION; GENE REARRANGEMENT; GENETIC PREDISPOSITION; HISTIOCYTIC SARCOMA; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; MAINTENANCE THERAPY; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; RECEPTOR GENE;

CELL SEPARATION; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FLOW CYTOMETRY; FURANS; GENES, P16; HISTIOCYTIC SARCOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASMS, SECOND PRIMARY; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; THIOPHENES;

EID: 78650101092     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22810     Document Type: Article

References (21)

1. Swerdlow S, Campo E, Harris N, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008.
2. Xie H, Ye M, Feng R, et al. Stepwise reprogramming of B cells into macrophages. Cell 2004; 117: 663-676.
3. Soslow RA, Davis RE, Warnke RA, et al. True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood 1996; 87: 5207-5212.
4. van der Kwast TH, van Dongen JJ, Michiels JJ, et al. T-lymphoblastic lymphoma terminating as malignant histiocytosis with rearrangement of immunoglobulin heavy chain gene. Leukemia 1991; 5: 78-82.
5. Feldman AL, Minniti C, Santi M, et al. Histiocytic sarcoma after acute lymphoblastic leukaemia: A common clonal origin. Lancet Oncol 2004; 5: 248-250.
6. McClure R, Khoury J, Feldman A, et al. Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: A case report and discussion in the context of similar cases. Leuk Res 2010; 34: e71-e73.
7. Costa da Cunha Castro E, Blazquez C, Boyd J, et al. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol 2009: 1.
8. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41: 1-29.
9. Vos JA, Abbondanzo SL, Barekman CL, et al. Histiocytic sarcoma: A study of five cases including the histiocyte marker CD163. Mod Pathol 2005; 18: 693-704.
10. Buonocore S, Valente AL, Nightingale D, et al. Histiocytic sarcoma in a 3-year-old male: A case report. Pediatrics 2005; 116: e322-e325.
11. El-Matary W, Thorburn K, Baillie C, et al. Histiocytic sarcoma presenting with chylous ascites in a 7-month-old infant: A case report. J Pediatr Hematol Oncol 2009; 31: 65-68.
12. Carrasco DR, Fenton T, Sukhdeo K, et al. The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell 2006; 9: 379-390.
13. Sulong S, Moorman AV, Irving JA, et al. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood 2009; 113: 100-107.
14. Bouabdallah R, Abena P, Chetaille B, et al. True histiocytic lymphoma following B-acute lymphoblastic leukaemia: Case report with evidence for a common clonal origin in both neoplasms. Br J Haematol 2001; 113: 1047-1050.
15. Feldman AL, Arber DA, Pittaluga S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: Evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008; 111: 5433-5439.
16. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 2007; 449: 473-477.
17. Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: Clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 2004; 28: 1133-1144.
18. Carrera CJ, Terai C, Lotz M, et al. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy. J Clin Invest 1990; 86: 1480-1488.
19. Rodriguez-Galindo C, Kelly P, Jeng M, et al. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Am J Hematol 2002; 69: 179-184.
20. Abidi MH, Tove I, Ibrahim RB, et al. Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant. Am J Hematol 2007; 82: 932-933.
21. Dalle JH, Leblond P, Decouvelaere A, et al. Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL. Leukemia 2003; 17: 2056-2057.